Townsquare Capital LLC Supernus Pharmaceuticals, Inc. Transaction History

Townsquare Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$27.11 - $35.17 $331,365 - $429,882	12,223 Added 40.44%	42,449 $1.45 Million
Q4 2023 Feb 15, 2024	BUY	$22.72 - $29.68 $137,546 - $179,682	6,054 Added 25.05%	30,226 $874,000
Q3 2023 Nov 15, 2023	BUY	$27.57 - $32.91 $175,262 - $209,208	6,357 Added 35.68%	24,172 $666,000
Q2 2023 Nov 13, 2023	BUY	$29.91 - $38.73 $79,201 - $102,557	2,648 Added 17.46%	17,815 $535,000
Q1 2023 May 11, 2023	BUY	$34.93 - $42.03 $95,219 - $114,573	2,726 Added 21.91%	15,167 $549,000
Q4 2022 Feb 13, 2023	BUY	$31.09 - $37.88 $68,180 - $83,070	2,193 Added 21.4%	12,441 $443,000
Q3 2022 Nov 10, 2022	BUY	$28.79 - $35.41 $45,171 - $55,558	1,569 Added 18.08%	10,248 $347,000
Q2 2022 Aug 08, 2022	BUY	$25.33 - $34.25 $219,839 - $297,255	8,679 New	8,679 $251,000

282

60.9M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.94B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Townsquare Capital LLC with notifications on news.